3/A

Filing

Apimeds Pharmaceuticals US, Inc. Filed 2025-06-11 Acc 0001474506-25-000108

Documents 1

3/A , xslF345X02/primary_doc.xml

Around this filing

2025-06-11 4/A 10% owner acquired 115,131 shares (conversion)
2025-06-11 3/A 3/A
2025-06-05 8-K Executive or director change
2025-05-14 3/A 3/A

Link to a passage

External

SEC EDGAR (opens in new tab)